Kobayashi Pharmaceutical Co., Ltd. Stock Deutsche Boerse AG
Stocks
KOY
JP3301100008
Personal Products
OTC Markets Traded|
Real-time Estimate
Tradegate
01:51:06 26/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 30.60 EUR | +4.08% |
|
+2.78% | +3.50% |
| Market Cap | 422B 2.65B 2.27B 2.13B 1.95B 3.67B 254B 3.71B 25.18B 9.79B 128B 9.97B 9.75B | P/E 2026 * |
41.1x | P/E 2027 * | 30.9x |
|---|---|---|---|---|---|
| Enterprise Value | 364B 2.29B 1.96B 1.84B 1.68B 3.17B 219B 3.2B 21.73B 8.45B 110B 8.6B 8.41B | EV / Sales 2026 * |
2.11x | EV / Sales 2027 * | 1.96x |
| Free-Float |
64.44% | Yield 2026 * |
1.88% | Yield 2027 * | 1.94% |
| 1 day | +4.08% | ||
| 1 week | +2.78% | ||
| Current month | +0.68% | ||
| 1 month | +2.78% | ||
| 3 months | -2.63% | ||
| 6 months | -1.99% | ||
| Current year | +3.50% |
| 1 week | 29 |  | 29.6 |
| 1 month | 28.8 | | 31.2 |
| Current year | 27.6 | | 32 |
| 1 year | 27.4 | | 32 |
| 3 years | 27.4 | | 44.8 |
| 5 years | 27.4 | | 79 |
| 10 years | 27.4 | | 104 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yumi Nakagawa
DFI | Director of Finance/CFO | - | - |
Toyoda Kaichi
PSD | President | 62 | 01/03/2025 |
Yuji Matsushima
CTO | Chief Tech/Sci/R&D Officer | 51 | 01/07/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 01/06/2004 | |
Yoshirou Katae
BRD | Director/Board Member | 69 | 01/03/2022 |
Yoshihito Ohta
CHM | Chairman | 72 | 28/03/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.08% | +2.78% | - | - | 2.63B | |
| -0.85% | +1.31% | -6.93% | -5.35% | 341B | |
| -0.44% | +4.01% | -7.87% | +4.85% | 140B | |
| -1.10% | +0.15% | +8.97% | +24.07% | 73.78B | |
| -0.29% | -1.50% | -23.03% | -21.58% | 49.81B | |
| -0.28% | +23.21% | +17.08% | -32.23% | 37.67B | |
| -0.90% | +2.61% | -8.97% | -16.02% | 37.32B | |
| +1.32% | +3.46% | +6.99% | +29.44% | 20.29B | |
| -0.18% | +3.62% | +8.97% | +10.08% | 20.09B | |
| +0.03% | +0.13% | -26.09% | -10.81% | 9.93B | |
| Average | +0.12% | +4.85% | -3.43% | -1.95% | 81.13B | |
| Weighted average by Cap. | -0.66% | +4.04% | -4.91% | -2.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 173B 1.08B 930M 870M 795M 1.5B 104B 1.52B 10.29B 4B 52.15B 4.07B 3.98B | 180B 1.13B 969M 906M 829M 1.56B 108B 1.58B 10.72B 4.17B 54.35B 4.24B 4.15B |
| Net income | 10.26B 64.47M 55.25M 51.68M 47.25M 89.17M 6.17B 90.12M 612M 238M 3.1B 242M 237M | 13.67B 85.96M 73.67M 68.91M 63M 119M 8.23B 120M 815M 317M 4.13B 323M 316M |
| Net Debt | -57.86B -364M -312M -292M -267M -503M -34.83B -508M -3.45B -1.34B -17.49B -1.37B -1.34B | -69.8B -439M -376M -352M -322M -607M -42.01B -613M -4.16B -1.62B -21.1B -1.65B -1.61B |
| Date | Price | Change |
|---|---|---|
| 25/08/26 | EUR 29.60 | +0.68% |
| 24/08/26 | EUR 29.40 | 0.00% |
| 21/08/26 | EUR 29.40 | 0.00% |
| 20/08/26 | EUR 29.40 | +1.38% |
| 19/08/26 | EUR 29.00 | +0.69% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4967 Stock
- KOY Stock
Select your edition
All financial news and data tailored to specific country editions
